AI Analysis

How does ANNX.ST make money? Does ANNX.ST have pricing power? What's the Earnings Whisper? Will ANNX.ST profit more as the business scales? What is ANNX.ST's management track record? Is ANNX.ST's current price justified?

Annexin Pharmaceuticals AB

SEK 6.64 -$13.26 (-66.63%)

STO · 30 Oct 2026 10:26 UTC

Previous Close

SEK 6.70

Day Range

SEK 6.52SEK 6.80

Year Range

SEK 6.52SEK 27.80

Market Cap

57.89M

AVG Volume

8.73K

Trailing/Forward PE

-1.51/-

PEG ratio

0.03

Dividend Yield

Next Earnings Date

Primary Exchange

Stockholm Stock Exchange

Net Income (SEK) · A

ANNX.ST Net Income (SEK) by year
Period	Net Income (SEK)
2025	-36.89M
2024	-50.25M
2023	-44.06M
2022	-40.73M
2021	-52.14M
2020	-44.24M
2019	-28.36M
2018	-28.85M
2017	-30.93M
2016	-9.83M

Operating Income (SEK) · A

ANNX.ST Operating Income (SEK) by year
Period	Operating Income (SEK)
2025	-36.87M
2024	-50.48M
2023	-44.18M
2022	-40.72M
2021	-51.23M
2020	-59.51M
2019	-28.33M
2018	-28.7M
2017	-30.85M
2016	-9.78M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (SEK) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Annexin Pharmaceuticals AB

Earnings: ANNX.ST

Video analysis: ANNX.ST

News: ANNX.ST

Similar companies